TapewireFind a company

person · Reporting owner

Beck Mark A

Disclosed activity across 4 companies

Tapewire entity
16375
SEC CIK
0001603310

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
ACCENDRA HEALTH INC/VA/ACH · Entity 6858DirectorMay 14, 2026May 18, 2026
DANAHER CORP /DE/DHR · Entity 2871Executive Vice PresidentMay 15, 2015July 29, 2015
IDEX CORP /DE/IEX · Entity 3323DirectorMay 06, 2026May 08, 2026
JELD-WEN Holding, Inc.JELD · Entity 6378Director · President & CEONovember 30, 2017December 04, 2017

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

ACCENDRA HEALTH INC/VA/

Report date May 14, 2026 · Filed May 18, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect71,259 Reported balance After 2026-05-14 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2026-05-14 · Grant · Acquired 31,191 · Balance 71,259

F1: Restricted stock grant which vests the earlier of (i) one year from the grant date and (ii) the date of the next annual meeting that is at least 50 weeks following the grant date.

Filing footnotes · ownership attribution and instrument terms

F1: Restricted stock grant which vests the earlier of (i) one year from the grant date and (ii) the date of the next annual meeting that is at least 50 weeks following the grant date.

DANAHER CORP /DE/

Report date May 15, 2015 · Filed July 29, 2015

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect0 Ending reported balance After 2015-07-28 transaction · row 2
2 source rows · reconciled sequence

Row 1 · 2015-05-15 · Tax withholding · Disposed 7,123 · Balance 6,890

F1: The transaction relates to the withholding of certain shares for tax purposes in connection with the vesting of performance-based restricted stock units.

Row 2 · 2015-07-28 · Sale · Disposed 6,890 · Balance 0

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.71 to $87.80, inclusive. The reporting person undertakes to provide to Danaher Corporation, any securityholder of Danaher Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes to this Form 4.

Filing footnotes · ownership attribution and instrument terms

F1: The transaction relates to the withholding of certain shares for tax purposes in connection with the vesting of performance-based restricted stock units.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.71 to $87.80, inclusive. The reporting person undertakes to provide to Danaher Corporation, any securityholder of Danaher Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes to this Form 4.

IDEX CORP /DE/

Report date May 06, 2026 · Filed May 08, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
COMMON STOCKSEC Table I · non-derivativeDirect7,755 Reported balance After 2026-05-06 transaction · row 1
1 source row

Row 1 · 2026-05-06 · Grant · Acquired 805 · Balance 7,755

F1: Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. These RSUs vest in full on the earlier of May 6, 2027, and the date of the Issuer's next annual stockholders meeting if it is at least 50 weeks after the prior year's meeting, subject to the Reporting Person's continuous service through such date.

Filing footnotes · ownership attribution and instrument terms

F1: Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. These RSUs vest in full on the earlier of May 6, 2027, and the date of the Issuer's next annual stockholders meeting if it is at least 50 weeks after the prior year's meeting, subject to the Reporting Person's continuous service through such date.

JELD-WEN Holding, Inc.

Report date November 30, 2017 · Filed December 04, 2017

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect204,668 Reported balance After 2017-11-30 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2017-11-30 · Tax withholding · Disposed 19,614 · Balance 204,668

F1: Shares reported were withheld for payment of taxes associated with the vesting of 41,250 restricted stock units originally granted on November 30, 2015. The balance of the shares were retained by the officer.

Filing footnotes · ownership attribution and instrument terms

F1: Shares reported were withheld for payment of taxes associated with the vesting of 41,250 restricted stock units originally granted on November 30, 2015. The balance of the shares were retained by the officer.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
May 14, 2026 Filed May 18, 2026 13:11 UTC ACCENDRA HEALTH INC/VA/ ACH · Entity 6858 GrantCommon Stock 31,191 $0.00 $0.00
Disclosure

SEC source: 0000075252-26-000024 · form4.xml · nonDerivative · entry 1

Beck Mark A · CIK 0001603310 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,259

F1 · security: Restricted stock grant which vests the earlier of (i) one year from the grant date and (ii) the date of the next annual meeting that is at least 50 weeks following the grant date.

Read SEC document
May 06, 2026 Filed May 8, 2026 20:34 UTC IDEX CORP /DE/ IEX · Entity 3323 GrantCOMMON STOCK 805 $0.00 $0.00
Disclosure

SEC source: 0000905148-26-002188 · form4.xml · nonDerivative · entry 1

Beck Mark A · CIK 0001603310 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,755

F1 · shares: Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. These RSUs vest in full on the earlier of May 6, 2027, and the date of the Issuer's next annual stockholders meeting if it is at least 50 weeks after the prior year's meeting, subject to the Reporting Person's continuous service through such date.

Read SEC document
May 15, 2025 Filed May 16, 2025 22:06 UTC ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 GrantCommon Stock 28,914 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-009721 · form4.xml · nonDerivative · entry 1

Beck Mark A · CIK 0001603310 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,068

F1 · security: Restricted stock grant which vests the earlier of (i) one year from the grant date and (ii) the date of the next annual meeting that is at least 50 weeks following the grant date.

Read SEC document
May 08, 2025 Filed May 12, 2025 21:52 UTC IDEX CORP /DE/ IEX · Entity 3323 GrantCOMMON STOCK 895 $0.00 $0.00
Disclosure

SEC source: 0000905148-25-001581 · form4.xml · nonDerivative · entry 1

Beck Mark A · CIK 0001603310 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,950

Read SEC document
June 05, 2024 Filed Jun 6, 2024 20:10 UTC ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 SaleCommon Stock 9,344 $17.25 $161,184.00
Disclosure

SEC source: 0001062993-24-012026 · form4.xml · nonDerivative · entry 1

Beck Mark A · CIK 0001603310 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,154

F1 · kind: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 4, 2024.

Read SEC document
May 09, 2024 Filed May 10, 2024 20:04 UTC ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 GrantCommon Stock 11,154 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-009878 · form4.xml · nonDerivative · entry 1

Beck Mark A · CIK 0001603310 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,498

F1 · security: Restricted stock grant which vests the earlier of (i) one year from the grant date and (ii) the date of the next annual meeting that is at least 50 weeks following the grant date.

Read SEC document
May 07, 2024 Filed May 8, 2024 19:57 UTC IDEX CORP /DE/ IEX · Entity 3323 GrantCOMMON STOCK 745 $0.00 $0.00
Disclosure

SEC source: 0000832101-24-000019 · primary_doc.xml · nonDerivative · entry 1

Beck Mark A · CIK 0001603310 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,055

Read SEC document
May 25, 2023 Filed May 30, 2023 19:24 UTC IDEX CORP /DE/ IEX · Entity 3323 GrantCOMMON STOCK 770 $0.00 $0.00
Disclosure

SEC source: 0001842832-23-000001 · primary_doc.xml · nonDerivative · entry 1

Beck Mark A · CIK 0001603310 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,310

Read SEC document
May 12, 2023 Filed May 12, 2023 23:33 UTC ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 GrantCommon Stock 9,344 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-010979 · form4.xml · nonDerivative · entry 1

Beck Mark A · CIK 0001603310 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,344

F1 · security: Restricted stock grant which vests the earlier of (i) one year from the grant date and (ii) the date of the next annual meeting that is at least 50 weeks following the grant date.

Read SEC document
May 06, 2022 Filed May 10, 2022 17:07 UTC IDEX CORP /DE/ IEX · Entity 3323 GrantCOMMON STOCK 825 $0.00 $0.00
Disclosure

SEC source: 0000832101-22-000019 · primary_doc.xml · nonDerivative · entry 1

Beck Mark A · CIK 0001603310 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,540

Read SEC document
April 29, 2022 Filed May 3, 2022 12:31 UTC ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 GrantPhantom Stock · Derivative 4,931 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-011321 · form4.xml · derivative · entry 2

Beck Mark A · CIK 0001603310 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,343

Underlying: Common Stock · 4,931 shares

Expires not disclosed

F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

Read SEC document
April 29, 2022 Filed May 3, 2022 12:31 UTC ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 GrantPhantom Stock · Derivative 1 $35.49 $35.49
Disclosure

SEC source: 0001062993-22-011321 · form4.xml · derivative · entry 1

Beck Mark A · CIK 0001603310 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,412

Underlying: Common Stock · 1 shares

Expires not disclosed

F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F2 · shares: Shares acquired through quarterly dividend reinvestment transaction.

F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

Read SEC document
December 31, 2021 Filed Jan 4, 2022 21:36 UTC ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 GrantPhantom Stock · Derivative 2 $43.50 $87.00
Disclosure

SEC source: 0001062993-22-000275 · form4.xml · derivative · entry 1

Beck Mark A · CIK 0001603310 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,411

Underlying: Common Stock · 2 shares

Expires not disclosed

F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F2 · shares: Shares acquired through quarterly dividend reinvestment transaction.

F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

Read SEC document
September 30, 2021 Filed Oct 1, 2021 20:29 UTC ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 GrantPhantom Stock · Derivative 3 $31.29 $93.87
Disclosure

SEC source: 0001062993-21-009072 · form4.xml · derivative · entry 1

Beck Mark A · CIK 0001603310 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,409

Underlying: Common Stock · 3 shares

Expires not disclosed

F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F2 · shares: Shares acquired through quarterly dividend reinvestment transaction.

F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

Read SEC document
June 30, 2021 Filed Jun 30, 2021 21:21 UTC ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 GrantPhantom Stock · Derivative 7 $42.33 $296.31
Disclosure

SEC source: 0000075252-21-000123 · edgar.xml · derivative · entry 1

Beck Mark A · CIK 0001603310 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,406

Underlying: Common Stock · 7 shares

Expires not disclosed

F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F2 · shares: Shares acquired through quarterly dividend reinvestment transaction.

F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

Read SEC document
May 12, 2021 Filed May 14, 2021 20:10 UTC IDEX CORP /DE/ IEX · Entity 3323 GrantCOMMON STOCK 665 $0.00 $0.00
Disclosure

SEC source: 0001226577-21-000001 · primary_doc.xml · nonDerivative · entry 1

Beck Mark A · CIK 0001603310 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,715

Read SEC document
April 29, 2021 Filed May 3, 2021 20:41 UTC ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 GrantPhantom Stock · Derivative 4,098 $0.00 $0.00
Disclosure

SEC source: 0000075252-21-000081 · edgar.xml · derivative · entry 1

Beck Mark A · CIK 0001603310 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,399

Underlying: Common Stock · 4,098 shares

Expires not disclosed

F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

Read SEC document
March 31, 2021 Filed Apr 2, 2021 12:29 UTC ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 GrantPhantom Stock · Derivative 2 $37.59 $75.18
Disclosure

SEC source: 0000075252-21-000065 · edgar.xml · derivative · entry 1

Beck Mark A · CIK 0001603310 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,301

Underlying: Common Stock · 2 shares

Expires not disclosed

F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F2 · shares: Shares acquired through quarterly dividend reinvestment transaction.

F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

Read SEC document
December 31, 2020 Filed Jan 5, 2021 13:17 UTC ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 GrantPhantom Stock · Derivative 2 $27.05 $54.10
Disclosure

SEC source: 0000075252-21-000001 · edgar.xml · derivative · entry 1

Beck Mark A · CIK 0001603310 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,299

Underlying: Common Stock · 2 shares

Expires not disclosed

F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F2 · shares: Shares acquired through quarterly dividend reinvestment transaction.

F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

Read SEC document
September 30, 2020 Filed Oct 1, 2020 21:35 UTC ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 GrantPhantom Stock · Derivative 2 $25.11 $50.22
Disclosure

SEC source: 0000075252-20-000124 · edgar.xml · derivative · entry 1

Beck Mark A · CIK 0001603310 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,297

Underlying: Common Stock · 2 shares

Expires not disclosed

F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F2 · shares: Shares acquired through quarterly dividend reinvestment transaction.

F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

Read SEC document
August 07, 2020 Filed Aug 11, 2020 20:32 UTC ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 GrantPhantom Stock · Derivative 18 $0.00 $0.00
Disclosure

SEC source: 0000075252-20-000108 · edgar.xml · derivative · entry 1

Beck Mark A · CIK 0001603310 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,295

Underlying: Common Stock · 18 shares

Expires not disclosed

F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F2 · shares: Shares acquired through quarterly dividend reinvestment transaction.

F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

Read SEC document
May 11, 2020 Filed May 13, 2020 01:43 UTC ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 GrantPhantom Stock · Derivative 17,242 $0.00 $0.00
Disclosure

SEC source: 0000075252-20-000062 · edgar.xml · derivative · entry 1

Beck Mark A · CIK 0001603310 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,277

Underlying: Common Stock · 17,242 shares

Expires not disclosed

F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

Read SEC document
May 07, 2020 Filed May 11, 2020 20:16 UTC IDEX CORP /DE/ IEX · Entity 3323 GrantCOMMON STOCK 950 $0.00 $0.00
Disclosure

SEC source: 0001574068-20-000002 · primary_doc.xml · nonDerivative · entry 1

Beck Mark A · CIK 0001603310 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,050

Read SEC document
August 07, 2019 Filed Aug 9, 2019 00:52 UTC ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 GrantPhantom Stock · Derivative 23,035 $4.07 $93,752.45
Disclosure

SEC source: 0000075252-19-000110 · edgar.xml · derivative · entry 1

Beck Mark A · CIK 0001603310 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,035

Underlying: Common Stock · 23,035 shares

Expires not disclosed

F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

Read SEC document
May 10, 2019 Filed May 14, 2019 20:29 UTC IDEX CORP /DE/ IEX · Entity 3323 GrantCOMMON STOCK 845 $0.00 $0.00
Disclosure

SEC source: 0001226577-19-000001 · primary_doc.xml · nonDerivative · entry 1

Beck Mark A · CIK 0001603310 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,100

Read SEC document
April 25, 2018 Filed Apr 26, 2018 21:10 UTC IDEX CORP /DE/ IEX · Entity 3323 GrantCOMMON STOCK 945 $0.00 $0.00
Disclosure

SEC source: 0001226577-18-000002 · primary_doc.xml · nonDerivative · entry 1

Beck Mark A · CIK 0001603310 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,255

Read SEC document
January 02, 2018 Filed Jan 3, 2018 21:03 UTC IDEX CORP /DE/ IEX · Entity 3323 GrantCOMMON STOCK 310 $0.00 $0.00
Disclosure

SEC source: 0001485532-18-000002 · primary_doc.xml · nonDerivative · entry 1

Beck Mark A · CIK 0001603310 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 310

Read SEC document
November 30, 2017 Filed Dec 4, 2017 23:56 UTC JELD-WEN Holding, Inc. JELD · Entity 6378 Tax withholdingCommon Stock 19,614 $39.11 $767,103.54
Disclosure

SEC source: 0001674335-17-000074 · wf-form4_151243178030827.xml · nonDerivative · entry 1

Beck Mark A · CIK 0001603310 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 204,668

F1 · security: Shares reported were withheld for payment of taxes associated with the vesting of 41,250 restricted stock units originally granted on November 30, 2015. The balance of the shares were retained by the officer.

Read SEC document
February 02, 2017 Filed Feb 6, 2017 21:29 UTC JELD-WEN Holding, Inc. JELD · Entity 6378 GrantStock Option (Right to Buy) · Derivative 195,885 $0.00 Strike: $27.59 $0.00
Disclosure

SEC source: 0001140361-17-004564 · doc1.xml · derivative · entry 2

Beck Mark A · CIK 0001603310 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 195,885

Underlying: Common Stock · 195,885 shares

Expires 2027-02-02

F2 · derivative.exercise_date: Subject to the reporting person's continued employment with the issuer, these options will vest ratably on February 2, 2018, February 2, 2019 and February 2, 2020.

Read SEC document
February 02, 2017 Filed Feb 6, 2017 21:29 UTC JELD-WEN Holding, Inc. JELD · Entity 6378 GrantCommon Stock 57,005 $0.00 $0.00
Disclosure

SEC source: 0001140361-17-004564 · doc1.xml · nonDerivative · entry 1

Beck Mark A · CIK 0001603310 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 224,282

F1 · security: The reported transaction is an award of restricted stock units in respect of the issuer's common stock. Subject to the reporting person's continued employment with the issuer, these restricted stock units will vest on February 2, 2020.

Read SEC document
July 28, 2015 Filed Jul 29, 2015 22:41 UTC DANAHER CORP /DE/ DHR · Entity 2871 SaleCommon Stock 6,890 $87.74 $604,507.93
Disclosure

SEC source: 0000313616-15-000089 · edgar.xml · nonDerivative · entry 2

Beck Mark A · CIK 0001603310 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.71 to $87.80, inclusive. The reporting person undertakes to provide to Danaher Corporation, any securityholder of Danaher Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes to this Form 4.

Read SEC document
May 15, 2015 Filed Jul 29, 2015 22:41 UTC DANAHER CORP /DE/ DHR · Entity 2871 Tax withholdingCommon Stock 7,123 $86.45 $615,783.35
Disclosure

SEC source: 0000313616-15-000089 · edgar.xml · nonDerivative · entry 1

Beck Mark A · CIK 0001603310 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,890

F1 · shares: The transaction relates to the withholding of certain shares for tax purposes in connection with the vesting of performance-based restricted stock units.

Read SEC document
February 24, 2015 Filed Feb 26, 2015 01:02 UTC DANAHER CORP /DE/ DHR · Entity 2871 GrantEmployee stock option (right to buy) · Derivative 44,330 $0.00 Strike: $87.04 $0.00
Disclosure

SEC source: 0000313616-15-000039 · edgar.xml · derivative · entry 1

Beck Mark A · CIK 0001603310 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,330

Underlying: Common Stock · 44,330 shares

Expires 2025-02-24

F1 · derivative.exercise_date: One-half of the options granted vest on each of the fourth and fifth anniversaries of the grant date.

Read SEC document
January 01, 2015 Filed Jan 5, 2015 22:09 UTC DANAHER CORP /DE/ DHR · Entity 2871 GrantExecutive Deferred Incentive Program - Danaher Stock Fund · Derivative 882 $85.71 Strike: $0.00 $75,596.22
Disclosure

SEC source: 0000313616-15-000001 · edgar.xml · derivative · entry 1

Beck Mark A · CIK 0001603310 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,574

Underlying: Common Stock · 882 shares

Expires not disclosed

F1 · security: Compensation deferred or contributed into the Danaher stock fund (the "EDIP Stock Fund") included in Danaher's Executive Deferred Incentive Program (the "EDIP") is deemed to be invested in a number of unfunded, notional shares of Danaher common stock based on the closing price of Danaher common stock as reported on the NYSE on the date such compensation is credited to the EDIP Stock Fund (or the closing price for the immediately preceding business day, if such date is not a business day). The price shown in Table II, Column 8 is the closing price per share of Danaher common stock applicable to the respective transaction date.

F2 · derivative.exercise_price: The notional shares convert on a one-for-one basis.

F1 · price: Compensation deferred or contributed into the Danaher stock fund (the "EDIP Stock Fund") included in Danaher's Executive Deferred Incentive Program (the "EDIP") is deemed to be invested in a number of unfunded, notional shares of Danaher common stock based on the closing price of Danaher common stock as reported on the NYSE on the date such compensation is credited to the EDIP Stock Fund (or the closing price for the immediately preceding business day, if such date is not a business day). The price shown in Table II, Column 8 is the closing price per share of Danaher common stock applicable to the respective transaction date.

F3 · derivative.exercise_date: The reporting person immediately vests in 100% of each voluntary contribution to the EDIP Stock Fund. The reporting person will vest in all company contributions to the EDIP Stock Fund as follows: 100% upon the earlier of the reporting person's death, or upon retirement following at least 5 years of service with Danaher and reaching the age of 55, or, if earlier, one-tenth per year of participation following five years of participation, in each case in accordance with the plan. Upon termination of employment, the vested portion of the EDIP Stock Fund is settled in Danaher common stock.

F3 · derivative.expiration_date: The reporting person immediately vests in 100% of each voluntary contribution to the EDIP Stock Fund. The reporting person will vest in all company contributions to the EDIP Stock Fund as follows: 100% upon the earlier of the reporting person's death, or upon retirement following at least 5 years of service with Danaher and reaching the age of 55, or, if earlier, one-tenth per year of participation following five years of participation, in each case in accordance with the plan. Upon termination of employment, the vested portion of the EDIP Stock Fund is settled in Danaher common stock.

F1 · derivative.underlying_shares: Compensation deferred or contributed into the Danaher stock fund (the "EDIP Stock Fund") included in Danaher's Executive Deferred Incentive Program (the "EDIP") is deemed to be invested in a number of unfunded, notional shares of Danaher common stock based on the closing price of Danaher common stock as reported on the NYSE on the date such compensation is credited to the EDIP Stock Fund (or the closing price for the immediately preceding business day, if such date is not a business day). The price shown in Table II, Column 8 is the closing price per share of Danaher common stock applicable to the respective transaction date.

F1 · balance_after: Compensation deferred or contributed into the Danaher stock fund (the "EDIP Stock Fund") included in Danaher's Executive Deferred Incentive Program (the "EDIP") is deemed to be invested in a number of unfunded, notional shares of Danaher common stock based on the closing price of Danaher common stock as reported on the NYSE on the date such compensation is credited to the EDIP Stock Fund (or the closing price for the immediately preceding business day, if such date is not a business day). The price shown in Table II, Column 8 is the closing price per share of Danaher common stock applicable to the respective transaction date.

Read SEC document
October 31, 2014 Filed Jan 14, 2015 22:34 UTC DANAHER CORP /DE/ DHR · Entity 2871 GrantExecutive Deferred Incentive Program - Danaher Stock Fund · Derivative 0.859 $80.40 Strike: $0.00 $69.06
Disclosure

SEC source: 0000313616-15-000013 · edgar.xml · derivative · entry 2

Beck Mark A · CIK 0001603310 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 692.071

Underlying: Common Stock · 0.859 shares

Expires not disclosed

F1 · security: The reported securities are notional dividend accruals on phantom shares in the Danaher stock fund (the "EDIP Stock Fund") under Danaher's Executive Deferred Incentive Program (the "EDIP"). The number of phantom shares accrued as a result of such notional dividend accruals is based on the closing price of Danaher common stock as reported on the NYSE on the date such dividend accruals are credited to the EDIP Stock Fund, which is the price shown in Table II, Column 8 above.

F2 · derivative.exercise_price: The notional shares convert on a one-for-one basis.

F3 · derivative.exercise_date: The reporting person immediately vests in 100% of each voluntary contribution to the EDIP Stock Fund. The reporting person will vest in all company contributions to the EDIP Stock Fund as follows: 100% upon the earlier of the reporting person's death, or upon retirement following at least 5 years of service with Danaher and reaching the age of 55, or, if earlier, one-tenth per year of participation following five years of participation, in each case in accordance with the plan. Upon termination of employment, the vested portion of the EDIP Stock Fund is settled in Danaher common stock.

F3 · derivative.expiration_date: The reporting person immediately vests in 100% of each voluntary contribution to the EDIP Stock Fund. The reporting person will vest in all company contributions to the EDIP Stock Fund as follows: 100% upon the earlier of the reporting person's death, or upon retirement following at least 5 years of service with Danaher and reaching the age of 55, or, if earlier, one-tenth per year of participation following five years of participation, in each case in accordance with the plan. Upon termination of employment, the vested portion of the EDIP Stock Fund is settled in Danaher common stock.

Read SEC document
July 25, 2014 Filed Jan 14, 2015 22:34 UTC DANAHER CORP /DE/ DHR · Entity 2871 GrantExecutive Deferred Incentive Program - Danaher Stock Fund · Derivative 0.912 $75.69 Strike: $0.00 $69.03
Disclosure

SEC source: 0000313616-15-000013 · edgar.xml · derivative · entry 1

Beck Mark A · CIK 0001603310 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 692.071

Underlying: Common Stock · 0.912 shares

Expires not disclosed

F1 · security: The reported securities are notional dividend accruals on phantom shares in the Danaher stock fund (the "EDIP Stock Fund") under Danaher's Executive Deferred Incentive Program (the "EDIP"). The number of phantom shares accrued as a result of such notional dividend accruals is based on the closing price of Danaher common stock as reported on the NYSE on the date such dividend accruals are credited to the EDIP Stock Fund, which is the price shown in Table II, Column 8 above.

F2 · derivative.exercise_price: The notional shares convert on a one-for-one basis.

F3 · derivative.exercise_date: The reporting person immediately vests in 100% of each voluntary contribution to the EDIP Stock Fund. The reporting person will vest in all company contributions to the EDIP Stock Fund as follows: 100% upon the earlier of the reporting person's death, or upon retirement following at least 5 years of service with Danaher and reaching the age of 55, or, if earlier, one-tenth per year of participation following five years of participation, in each case in accordance with the plan. Upon termination of employment, the vested portion of the EDIP Stock Fund is settled in Danaher common stock.

F3 · derivative.expiration_date: The reporting person immediately vests in 100% of each voluntary contribution to the EDIP Stock Fund. The reporting person will vest in all company contributions to the EDIP Stock Fund as follows: 100% upon the earlier of the reporting person's death, or upon retirement following at least 5 years of service with Danaher and reaching the age of 55, or, if earlier, one-tenth per year of participation following five years of participation, in each case in accordance with the plan. Upon termination of employment, the vested portion of the EDIP Stock Fund is settled in Danaher common stock.

Read SEC document
May 15, 2014 Filed May 19, 2014 21:27 UTC DANAHER CORP /DE/ DHR · Entity 2871 GrantEmployee stock option (right to buy) · Derivative 35,600 $0.00 Strike: $74.97 $0.00
Disclosure

SEC source: 0000313616-14-000059 · edgar.xml · derivative · entry 1

Beck Mark A · CIK 0001603310 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,600

Underlying: Common Stock · 35,600 shares

Expires 2024-05-15

F1 · derivative.exercise_date: Fifty percent of the options granted vest on each of the fourth and fifth anniversaries of the grant date.

Read SEC document
May 01, 2014 Filed May 2, 2014 11:28 UTC DANAHER CORP /DE/ DHR · Entity 2871 GrantExecutive Deferred Incentive Program -- Danaher Stock Fund · Derivative 690.3 $73.38 Strike: $0.00 $50,654.21
Disclosure

SEC source: 0000313616-14-000046 · edgar.xml · derivative · entry 1

Beck Mark A · CIK 0001603310 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 690.3

Underlying: Common Stock · 690.3 shares

Expires not disclosed

F1 · security: Compensation deferred or contributed into the Danaher stock fund (the "EDIP Stock Fund") included in Danaher's Executive Deferred Incentive Program (the "EDIP") is deemed to be invested in a number of unfunded, notional shares of Danaher common stock based on the closing price of Danaher common stock as reported on the NYSE on the last business day before the date such compensation is credited to the EDIP Stock Fund. The price shown in Table II, Column 8 above is the closing price per share of Danaher common stock as reported on the NYSE on April 30, 2014.

F2 · derivative.exercise_price: The notional shares convert on a one-for-one basis.

F3 · kind: In accordance with the terms of the EDIP, in connection with the reporting person's commencement of employment with Danaher, Danaher credited a specified amount to the EDIP Stock Fund of the reporting person as of May 1, 2014, which amount has been deemed to be invested in a number of unfunded, notional shares of Danaher common stock based on the closing price of Danaher common stock as reported on the NYSE on April 30, 2014.

F1 · price: Compensation deferred or contributed into the Danaher stock fund (the "EDIP Stock Fund") included in Danaher's Executive Deferred Incentive Program (the "EDIP") is deemed to be invested in a number of unfunded, notional shares of Danaher common stock based on the closing price of Danaher common stock as reported on the NYSE on the last business day before the date such compensation is credited to the EDIP Stock Fund. The price shown in Table II, Column 8 above is the closing price per share of Danaher common stock as reported on the NYSE on April 30, 2014.

F4 · derivative.exercise_date: The reporting person immediately vests in 100% of each voluntary contribution to the EDIP Stock Fund. The reporting person will vest in all company contributions to the EDIP Stock Fund as follows: 100% upon the earlier of the reporting person's death, or upon retirement following at least 5 years of service with Danaher and reaching the age of 55, or, if earlier, one-tenth per year of participation following five years of vesting participation, in each case in accordance with the plan. Upon termination of employment, the vested portion of the EDIP Stock Fund is settled in Danaher common stock.

F4 · derivative.expiration_date: The reporting person immediately vests in 100% of each voluntary contribution to the EDIP Stock Fund. The reporting person will vest in all company contributions to the EDIP Stock Fund as follows: 100% upon the earlier of the reporting person's death, or upon retirement following at least 5 years of service with Danaher and reaching the age of 55, or, if earlier, one-tenth per year of participation following five years of vesting participation, in each case in accordance with the plan. Upon termination of employment, the vested portion of the EDIP Stock Fund is settled in Danaher common stock.

F1 · derivative.underlying: Compensation deferred or contributed into the Danaher stock fund (the "EDIP Stock Fund") included in Danaher's Executive Deferred Incentive Program (the "EDIP") is deemed to be invested in a number of unfunded, notional shares of Danaher common stock based on the closing price of Danaher common stock as reported on the NYSE on the last business day before the date such compensation is credited to the EDIP Stock Fund. The price shown in Table II, Column 8 above is the closing price per share of Danaher common stock as reported on the NYSE on April 30, 2014.

F1 · balance_after: Compensation deferred or contributed into the Danaher stock fund (the "EDIP Stock Fund") included in Danaher's Executive Deferred Incentive Program (the "EDIP") is deemed to be invested in a number of unfunded, notional shares of Danaher common stock based on the closing price of Danaher common stock as reported on the NYSE on the last business day before the date such compensation is credited to the EDIP Stock Fund. The price shown in Table II, Column 8 above is the closing price per share of Danaher common stock as reported on the NYSE on April 30, 2014.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.